Drug Shortage Report for ACT LEVOFLOXACIN

Last updated on 2019-05-28 History
Report ID 52485
Drug Identification Number 02315432
Brand name ACT LEVOFLOXACIN
Common or Proper name LEVOFLOXACIN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-15
Estimated end date 2019-05-31
Actual end date 2019-05-15
Shortage status Resolved
Updated date 2019-05-28
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-05-28 French Compare
v17 2019-05-28 English Compare
v16 2019-04-26 French Compare
v15 2019-04-26 English Compare
v14 2019-04-11 French Compare
v13 2019-04-11 English Compare
v12 2019-03-12 French Compare
v11 2019-03-12 English Compare
v10 2019-01-31 French Compare
v9 2019-01-31 English Compare
v8 2018-11-08 French Compare
v7 2018-11-08 English Compare
v6 2018-10-11 French Compare
v5 2018-10-11 English Compare
v4 2018-09-12 French Compare
v3 2018-09-12 English Compare
v2 2018-06-15 French Compare
v1 2018-06-15 English Compare